- Home
- STLNW vs MTNB Comparison
STLNW vs MTNB Comparison
Compare STLNW & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.07
N/A
Current Price
$0.20
Company Overview
Basic Information| Metric | STLNW | MTNB |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 5.2M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | STLNW | MTNB |
|---|---|---|
| Price | $0.07 | $0.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 962.7K |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.94 | ★ 59.84 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $502,729,000.00 | $119,750.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.79 | N/A |
| 52 Week Low | $0.04 | $0.18 |
| 52 Week High | $0.07 | $2.14 |
Technical Indicators
Market Signals| Indicator | STLNW | MTNB |
|---|---|---|
| Relative Strength Index (RSI) | 64.05 | 34.74 |
| Support Level | $0.05 | $0.18 |
| Resistance Level | $0.07 | $0.27 |
| Average True Range (ATR) | 0.01 | 0.02 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 89.66 | 16.10 |
Price Performance
Historical Comparison STLNW
MTNB
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.